Suppr超能文献

[结外鼻型NK/T细胞淋巴瘤:55例临床病理及预后研究]

[Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].

作者信息

Li Li, Liu Yan-hui, Zhuang Heng-guo, Luo Xin-lan, Zhang Fen, Xu Fang-ping, Luo Dong-lan

机构信息

Department of Pathology and Laboratory Medicine, Guangdong General Hospital (Guangdong Academy of Medicine Science), Guangzhou 510080, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2009 Apr;38(4):237-42.

Abstract

OBJECTIVE

To study the clinicopathologic features and prognostic factors of extranodal nasal type NK/T-cell lymphoma (EN-NK/TCL) in Chinese patients.

METHODS

Fifty-five cases of EN-NK/TCL diagnosed in Chinese patients during the period from 1998 to 2007 were studied by light microscopy, immunohistochemistry and in-situ hybridization. The follow-up information was analyzed.

RESULTS

The male-to-female ratio was 1.89:1. The median age of the patients was 38 years. The commonest sites of involvement included nasal cavity and adjoining tissue (85.5%). Histologically, EN-NK/TCL was composed of small to medium-sized lymphoid cells. Angiocentric and angiodestructive growth patterns, coagulative tumor necrosis and apoptotic bodies were frequently observed. Immunohistochemical study showed that CD20, the B-cell marker, was negative in all cases. The positivity rates for T-cell markers CD3epsilon, CD4, CD5 and CD8 were 100% (49/49), 7% (3/46), 8% (4/48) and 63% (29/46), respectively. Most cases were also positive for NK-cell marker CD56 (79% 42/53). All cases expressed cytotoxic granule-associated proteins TIA-1 and granzyme B. Only 17% (8/46) of the cases were positive for anti-apoptotic protein bcl-2. The proliferation index, as demonstrated by Ki-67 immunostain, varied: 30% (14/47) with a low Ki-67 expression level (< or = 29%), 28% (13/47) with a medium level (30%-59%) and 42% with a high level (> or = 60%). There was a significant positive correlation between the bcl-2 positive expression and a high Ki-67 expression level. In-situ hybridization for EBV-encoded RNA was positive in all cases. Amongst the 41 cases with clinical information available, 63.4% presented with Ann Arbor stage I to II. The performance status score was 1 in 87.8% cases. High lactate dehydrogenase level was demonstrated in some patients (31.8%). Amongst the 27 cases with follow-up data available, the median survival was 13 months. The overall 1-year, 2-year and 5-year survival rates were 52%, 31% and 20%, respectively. In general, cases with high proliferation index carried poor prognosis.

CONCLUSIONS

EN-NK/TCL is a mature T-cell and NK-cell neoplasm which can be accurately diagnosed by histologic examination, immunohistochemical study and in-situ hybridization. The prognosis is usually not favorable. Proliferation index of the tumor represents an independent prognostic factor.

摘要

目的

研究中国患者结外鼻型NK/T细胞淋巴瘤(EN-NK/TCL)的临床病理特征及预后因素。

方法

对1998年至2007年期间诊断为EN-NK/TCL的55例中国患者进行光镜、免疫组化及原位杂交研究,并分析随访信息。

结果

男女比例为1.89∶1。患者中位年龄为38岁。最常见的受累部位包括鼻腔及毗邻组织(85.5%)。组织学上,EN-NK/TCL由小至中等大小的淋巴细胞组成。常可见血管中心性和血管破坏性生长模式、凝固性肿瘤坏死及凋亡小体。免疫组化研究显示,B细胞标志物CD20在所有病例中均为阴性。T细胞标志物CD3ε、CD4、CD5和CD8的阳性率分别为100%(49/49)、7%(3/46)、8%(4/48)和63%(29/46)。多数病例NK细胞标志物CD56也呈阳性(79%,42/53)。所有病例均表达细胞毒性颗粒相关蛋白TIA-1和颗粒酶B。仅17%(8/46)的病例抗凋亡蛋白bcl-2呈阳性。Ki-67免疫染色显示的增殖指数各异:低Ki-67表达水平(≤29%)者占30%(14/47),中等水平(30% - 59%)者占28%(13/47),高水平(≥60%)者占42%。bcl-2阳性表达与高Ki-67表达水平之间存在显著正相关。EBV编码RNA原位杂交在所有病例中均为阳性。在有临床信息的41例患者中,63.4%为Ann Arbor I至II期。87.8%的病例体能状态评分为1。部分患者乳酸脱氢酶水平升高(31.8%)。在有随访数据的27例患者中,中位生存期为13个月。1年、2年和5年总生存率分别为52%、31%和20%。总体而言,增殖指数高的病例预后较差。

结论

EN-NK/TCL是一种成熟的T细胞和NK细胞肿瘤,可通过组织学检查、免疫组化研究及原位杂交准确诊断。其预后通常不佳。肿瘤增殖指数是独立的预后因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验